Evidence map›Paper›PMID 41107360›Full record

ArticleScientific reports2025

In-cell NMR spectra of chemically unmodified RNA at physiological temperature with extended lifetime through RNase inhibitor cocktail in living human cells.

Omar Eladl, Yudai Yamaoki, Takashi Nagata, Masato Katahira

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Short peptide 803sp inhibits the inflammatory response induced byFrontiers in cellular and infection microbiology · 2026
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Omar Eladl *Institute of Advanced Energy, Kyoto University, Kyoto, 611-0011, Japan.
Yudai Yamaoki *Institute of Advanced Energy, Kyoto University, Kyoto, 611-0011, Japan.
Takashi NagataInstitute of Advanced Energy, Kyoto University, Kyoto, 611-0011, Japan.
Masato KatahiraInstitute of Advanced Energy, Kyoto University, Kyoto, 611-0011, Japan. katahira.masato.6u@kyoto-u.ac.jp.

Funding

Institute for Protein Research, Osaka University NMRCR-24-03Institute of Advanced Energy ZE2024A-11Institute of Advanced Energy, Kyoto University ZE2024A-06Institute of Advanced Energy, Kyoto University ZE2024A-15Japan Agency for Medical Research and Development 24fk0410048h0103Japan Society for the Promotion of Science 20K06524Japan Society for the Promotion of Science 22K05314Japan Society for the Promotion of Science 23H02419
6 · The paper itself

Abstract

The crowded intracellular environment influences RNA structure and interactions. While in-cell nuclear magnetic resonance (NMR) spectroscopy allows atomic-resolution studies of RNA in living human cells, its application is limited due to rapid RNA degradation. In this study, we introduced an RNase inhibitor cocktail into living human cells and acquired in-cell NMR spectra of an RNA aptamer that strongly binds to HIV-1 Tat, both with and without a peptide derived from Tat. Introduction of the RNase inhibitor cocktail effectively suppressed RNA degradation. The significantly extended lifetime enabled the observation of intact in-cell NMR spectra for both the free aptamer and its complex with the peptide in living human cells at physiological temperatures. The in-cell NMR spectra of the free and complexed forms provided structural insights into RNA in living cells for understanding the mechanism of tight binding, including the formation of U-A-U base triples only in the complex. This was achieved without chemical modifications to the aptamer. The easily applicable and cost-effective nature of the RNase inhibitor cocktail makes this technique suitable for a wide range of in-cell NMR analyses for RNA. This innovation offers a pathway to unravel cellular processes and design novel RNA-focused medications.

Indexed as

Enzyme InhibitorsRibonucleasesRNAAptamers, NucleotideHIV-1HumansMagnetic Resonance SpectroscopyNucleic Acid ConformationRNA Stabilitytat Gene Products, Human Immunodeficiency VirusTemperatureAptamers, NucleotideEnzyme InhibitorsRibonucleasesRNAtat Gene Products, Human Immunodeficiency VirusIn-cell NMRInteractionRNA aptamerRNase inhibitorRNA structureU-A-U base triples

Identifiers

PMID41107360
PMCPMC12534491

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.